Please login to the form below

Not currently logged in
Email:
Password:

omalizumab

This page shows the latest omalizumab news and features for those working in and with pharma, biotech and healthcare.

AZ prices severe asthma drug Fasenra below competition

AZ prices severe asthma drug Fasenra below competition

Along with Nucala and Cinqair, severe asthma patients can also be treated with Novartis’older drug Xolair (omalizumab), although that is indicated for allergic asthma and doesn’t specifically address eosinophilic

Latest news

More from news
Approximately 8 fully matching, plus 20 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Light_bulb_Stock_Market.jpg
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...

Infographics